Lakefront Biotherapeutics NV Shares Rise on Euronext Amsterdam
1 report, 1 independent
Updated Sep 1
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Lakefront Biotherapeutics NV, a company founded in 1999 and headquartered in Mechelen, Belgium, is trading on Euronext Amsterdam. The company completed its rebrand from Galapagos NV to Lakefront Biotherapeutics on May 8. On September 1, shares gained 7.36%, reaching €28.30 on the exchange.
From ibtimes.com.au
Why it matters
The company focuses on identifying, acquiring, and advancing promising drug candidates in therapeutic areas with significant unmet medical need. The stock movement reflects market activity following the company's strategic overhaul and successful transition to the new corporate identity.
From ibtimes.com.au
Who's involved
- AmsterdamHeadquarters of the company, Lakefront Biotherapeutics NV